Jon Isaacsohn is the founder of CinRx Pharma. CinRx Pharma has raised $176M in total funding. Latest round: Series B. Backed by Perceptive Advisors.
Jon Isaacsohn is the Founder and Chief Executive Officer of CinRx Pharma, a hub-and-spoke biotech company that accelerates high-impact medicines. The company has raised a total of $176 million and has launched five companies, or "CinCos," primarily focused on cardiovascular, metabolic, and gastrointestinal conditions. Isaacsohn previously oversaw the formation and exit of CinCor Pharma, which was acquired by AstraZeneca for $1.8 billion.
Full founder directory · Investor directory · Company funding database · Fundraising library